HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.

Abstract
Macrophage colony-stimulating factor (M-CSF), matrix metalloproteinase-2 (MMP-2) and its specific tissue inhibitor (TIMP-2) may play an important role in the pathogenesis of cancer disease. We investigated the plasma levels and diagnostic power (ROC curve analysis) of M-CSF, MMP-2, TIMP-2 and tumor markers CA 125 and SCC-Ag in cervical cancer (CC) patients as compared to control group. The study included 89 patients with cervical cancer. The control group consisted of 50 healthy, untreated women. The plasma levels of M-CSF, MMP-2 and TIMP-2 were determined using ELISA, CA 125 and SCC-Ag - by CMIA method. The median levels of M-CSF, TIMP-2, SCC-Ag and CA 125 in the entire group of CC were significantly different than compared to the healthy women group. MMP-2 showed the highest value of sensitivity from all examined parameters (in stage I of CC - 93.10%, II - 82.76%, III and IV - 96.88%, total group - 92.05%). The highest specificity was obtained by M-CSF (86%). The area under the ROC curve (AUC) of M-CSF (0.8051) was the largest of all the tested parameters (even higher than commonly used tumor markers) in the group of cervical cancer. The combination of M-CSF, MMP-2 or TIMP-2 with SCC antigen resulted in an increase AUCs in all cases (0.8760;0.7880;0.8081;respectively). The findings of this study suggest the usefulness of all examined parameters in the diagnostics of CC patients. Out of the tested substances, M-CSF also appears to be the best candidate for cancer diagnostics in all stages of the disease, based on ROC analysis.
AuthorsEmilia Lubowicka, Monika Zbucka-Kretowska, Iwona Sidorkiewicz, Monika Zajkowska, Ewa Gacuta, Andrzej Puchnarewicz, Lech Chrostek, Maciej Szmitkowski, Sławomir Ławicki
JournalPathology oncology research : POR (Pathol Oncol Res) Vol. 26 Issue 2 Pg. 791-800 (Apr 2020) ISSN: 1532-2807 [Electronic] Switzerland
PMID30820752 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • TIMP2 protein, human
  • Tissue Inhibitor of Metalloproteinase-2
  • Macrophage Colony-Stimulating Factor
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
Topics
  • Adult
  • Biomarkers, Tumor (blood)
  • Female
  • Humans
  • Macrophage Colony-Stimulating Factor (blood)
  • Matrix Metalloproteinase 2 (blood)
  • Middle Aged
  • ROC Curve
  • Sensitivity and Specificity
  • Tissue Inhibitor of Metalloproteinase-2 (blood)
  • Uterine Cervical Neoplasms (blood, diagnosis)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: